Amedisys, Inc. (AMED) was a big mover last session with its shares rising roughly 9% on the day. The upside was a result of research firm Sun Trust Rbsn upgrading its rating on the company from ‘neutral’ to ‘buy’. This development led to far more shares changing hands yesterday than in a normal session. This continues the recent uptrend of the company as the stock has gained roughly 21% in the past one-month time frame.
This provider of home health and hospice care services has seen 6 positive estimate revisions over the past 30 days. The Zacks Consensus Estimate has also moved considerably higher over the same period. This implies solid trading potential for the company. So make sure to keep an eye on this stock going forward to see if yesterday’s rally can turn into more strength down the road.
Amedisys currently holds a Zacks Rank #1 (Strong Buy) while its Earnings ESP is 0.00%.
Investors interested in the same industry may also consider AmSurg Corp. (AMSG) which carries a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment